| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
92,610,000 |
| Market
Cap: |
2.09(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.07 - $31.94 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. Co. has three clinical-stage ex vivo lentiviral vector. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction, and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,355,932 |
| Total Buy Value |
$0 |
$0 |
$0 |
$19,999,997 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
383,955 |
418,811 |
461,522 |
487,632 |
| Total Sell Value |
$10,553,228 |
$11,591,581 |
$12,480,377 |
$12,990,263 |
| Total People Sold |
5 |
7 |
7 |
8 |
| Total Sell Transactions |
8 |
13 |
21 |
29 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Militello John |
See Remarks |
• • – |
2024-01-22 |
4 |
S |
$27.20 |
$17,356 |
D/D |
(638) |
10,159 |
|
17% |
|
| Militello John |
See Remarks |
• • – |
2024-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,586 |
10,797 |
|
- |
|
| Makker Gotham |
|
• • – |
2023-11-15 |
4 |
S |
$22.53 |
$450,646 |
I/I |
(20,000) |
1,296,497 |
|
-25% |
|
| Militello John |
See Remarks |
• • – |
2023-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
725 |
9,485 |
|
- |
|
| Patel Kinnari |
See Remarks |
• • – |
2023-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,989 |
220,437 |
|
- |
|
| Shah Gaurav |
CEO |
• • – |
2023-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,979 |
532,833 |
|
- |
|
| Militello John |
See Remarks |
• • – |
2023-10-20 |
4 |
S |
$17.06 |
$9,623 |
D/D |
(564) |
8,760 |
|
-78% |
|
| Militello John |
See Remarks |
• • – |
2023-10-18 |
4/A |
OE |
$0.00 |
$0 |
D/D |
1,586 |
9,324 |
|
- |
|
| Patel Kinnari |
See Remarks |
• • – |
2023-10-05 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,333 |
101,594 |
|
- |
|
| Makker Gotham |
|
• • – |
2023-09-29 |
4 |
S |
$21.14 |
$98,864 |
I/I |
(4,677) |
1,316,497 |
|
-43% |
|
| Makker Gotham |
|
• • – |
2023-09-28 |
4 |
S |
$21.03 |
$216,880 |
I/I |
(10,312) |
1,321,174 |
|
-39% |
|
| Wong Roderick |
Director |
– • • |
2023-08-28 |
4 |
A |
$15.87 |
$7,935,000 |
I/I |
500,000 |
18,157,605 |
|
- |
|
| Wong Roderick |
Director |
– • • |
2023-08-28 |
4 |
D |
$15.87 |
$18,960,000 |
I/I |
(1,000,000) |
17,657,605 |
|
- |
|
| Wong Roderick |
Director |
– • • |
2023-08-28 |
4 |
A |
$22.05 |
$11,025,000 |
I/I |
500,000 |
18,657,605 |
|
- |
|
| Shah Gaurav |
CEO |
• • – |
2023-08-17 |
4 |
S |
$15.47 |
$73,750 |
D/D |
(4,767) |
524,854 |
|
-103% |
|
| Patel Kinnari |
See Remarks |
• • – |
2023-08-17 |
4 |
S |
$15.47 |
$23,733 |
D/D |
(1,534) |
216,448 |
|
-103% |
|
| Militello John |
See Remarks |
• • – |
2023-08-17 |
4 |
S |
$15.47 |
$4,394 |
D/D |
(284) |
5,570 |
|
-103% |
|
| Patel Kinnari |
See Remarks |
• • – |
2023-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,989 |
217,982 |
|
- |
|
| Shah Gaurav |
CEO |
• • – |
2023-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,979 |
529,621 |
|
- |
|
| Militello John |
See Remarks |
• • – |
2023-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
725 |
7,854 |
|
- |
|
| Militello John |
See Remarks |
• • – |
2023-07-20 |
4 |
S |
$19.03 |
$10,906 |
D/D |
(573) |
7,129 |
|
-24% |
|
| Militello John |
See Remarks |
• • – |
2023-07-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,586 |
7,702 |
|
- |
|
| Militello John |
See Remarks |
• • – |
2023-05-17 |
4 |
S |
$21.38 |
$5,237 |
D/D |
(245) |
6,116 |
|
5% |
|
| Shah Gaurav |
CEO |
• • – |
2023-05-17 |
4 |
S |
$21.38 |
$88,108 |
D/D |
(4,122) |
521,642 |
|
5% |
|
| Patel Kinnari |
See Remarks |
• • – |
2023-05-17 |
4 |
S |
$21.38 |
$28,429 |
D/D |
(1,330) |
213,993 |
|
5% |
|
69 Records found
|
|
Page 2 of 3 |
|
|
0.78 (3.33%) 
